ANA MEJIA JIMENEZ: Open Payments
NPI 1760108187 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,371 in 59 payments from 9 companies in 2025. Trend: 2023 $80 · 2024 $1,010 · 2025 $1,371
Food & beverage: $1,371
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $312 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $238 |
| Axsome Therapeutics, Inc. | 8 | $206 |
| Janssen Pharmaceuticals, Inc | 7 | $169 |
| Corium, LLC | 6 | $169 |
| Otsuka America Pharmaceutical, Inc. | 6 | $145 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $52 |
| Vanda Pharmaceuticals Inc. | 2 | $47 |
| E.R. Squibb & Sons, L.L.C. | 1 | $33 |
Products named: VRAYLAR, CAPLYTA, Auvelity, SPRAVATO, Azstarys, REXULTI, TRINTELLIX, COBENFY.
Industry payments across FL — which companies pay providers there.
